CoSyne Therapeutics

About:

Precision medicine through polymathic AI

Website: https://cosynerapeutics.com/

Top Investors: Amino Collective, BACKED VC, Meltwind Advisory

Description:

CoSyne Therapeutics is a vertically integrated AI Drug Discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served diseases of the brain.

Total Funding Amount:

$8.81M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2021-01-01

Contact Email:

louwai(AT)cosynerapeutics.com

Founders:

Liisi Laaniste, Louwai Muhammed

Number of Employees:

11-50

Last Funding Date:

2022-05-20

IPO Status:

Private

Industries: